Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 89226-50-6
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15DAY
Payment Terms: L/C,D/A,D/P,Western Union,T/T,MoneyGram
Supply Ability: G,KG,TON
Appearance:: |
Light Yellow Crystalline Solid |
CAS NO:: |
89226-50-6 |
Molecular Formula:: |
C35H38N4O6 |
Molecular Weight:: |
610.69900 |
EINECS NO:: |
855-394-4 |
MDL NO:: |
MFCD00871291 |
Appearance:: |
Light Yellow Crystalline Solid |
CAS NO:: |
89226-50-6 |
Molecular Formula:: |
C35H38N4O6 |
Molecular Weight:: |
610.69900 |
EINECS NO:: |
855-394-4 |
MDL NO:: |
MFCD00871291 |
Product Description:
Product Name: Manidipine CAS NO: 89226-50-6
Synonyms:
1-diphenylmethyl-4-(2-hydroxyethyl)piperazine;
3-{2-[4-(diphenylMethyl)piperazin-1-yl]ethyl}5-Methyl2,6-diMethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;
Manidipine 6300;
Chemical & Physical Properties:
Appearance: Light yellow crystalline solid
Assay :≥99.00%
Density: 1.232 g/cm3
Boiling Point: 722℃ at 760 mmHg
Melting Point: 125-128℃
Flash Point: 390.4℃
Storage Condition: -20℃ Freezer
Vapor Pressure: 0.0±2.3 mmHg at 25℃
Index of Refraction: 1.601
A dihydropyridine calcium channel blocker. Antihypertensive. Manidipine (Manyper) is a lipophilic, third-generation, highly vasoselective dihydropyridine calcium antagonist with an IC50 of 2.6 nM. It causes systemic vasodilation by inhibiting the voltage-dependent calcium inward currents in smooth muscle cells.
Manidipine is a calcium channel blocker that is used clinically as an antihypertensive. Target: Calcium ChannelManidipine is a dihydropyridine calcium antagonist, which causes systemic vasodilation by inhibiting the voltage-dependent calcium inward currents in smooth muscle cells. Manidipine was well tolerated in clinical trials, with most adverse effects related to vasodilation [1]. Manidipine is a lipophilic, third-generation dihydropyridine calcium channel antagonist with a high degree of selectivity for the vasculature, thereby inducing marked peripheral vasodilation with negligible cardiodepression. manidipine represents a first-line treatment option for patients with essential mild-to-moderate hypertension [2]. Manidipine has neutral effects on glucose and lipid metabolism and is generally well tolerated. Manidipine thus represents a first-line option for lowering BP in patients with mild-to-moderate hypertension [3].
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.